BSG and COVID-19: Furthermore, considering CD147’s involvement in fibrosis progression [61,62,63], particularly in its HG form [59], these findings collectively support the notion that CD147 could be a valuable target for mitigating COVID-19 disease and post-COVID-19 conditions.